28 results on '"Lilia Soufir"'
Search Results
2. Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study
- Author
-
Paul Michel Mertes, Nadine Petitpain, Charles Tacquard, Marion Delpuech, Cédric Baumann, Jean Marc Malinovsky, Dan Longrois, Aurélie Gouel-Cheron, Diane Le Quang, Pascal Demoly, Jean Louis Guéant, Pierre Gillet, Emmanuelle Aguinet, Pol André Apoil, Jean Eric Autegarden, Faiza Bettayeb, Céline Biermann, Maryline Bordes-demolis, Anca Chiriac, Pierre Antoine Darene, Frédéric Deblay, Sabrina Dessard, Charles Dzviga, Hassan El Hanache, Alain Facon, Yannick Fuhrer, Noémie Gest, Marion Gouitaa, Adela Harpan, Cyrille Hoarau, Lisa Le Guillou, Laurence Lepeltier, Claire Mailhol, Delphine Mariotte, Yannick Meunier, Isabelle Migueres, Martine Morisset, Catherine Neukirch, Dalila Nouar, Yann Ollivier, Isabelle Orsel, Omar Outtas, Minaxi Patel, Christelle Pellerin, Isabelle Petit, Anaïs Pipet, Cécile Rochefort-Morel, Claire Schwartz, Sandrine Seltzer, Alice Seringulian, Angèle Soria, Lilia Soufir, Rodolphe Stenger, Céline Tummino, Marion Verdaguer, Les Hôpitaux Universitaires de Strasbourg (HUS), Biologie et Pharmacologie des Plaquettes sanguines : hémostase, thrombose, transfusion (BPP), Université de Strasbourg (UNISTRA)-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg (UNISTRA), Nouvel Hôpital Civil de Strasbourg, Centre Régional de PharmacoVigilance de Lorraine (CRPV Lorraine), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Département Méthodologie Promotion Investigation [CHRU Nancy] (MPI), Centre Hospitalier Universitaire de Reims (CHU Reims), Hémostase et Remodelage Vasculaire Post-Ischémie (HERVI - EA 3801), Université de Reims Champagne-Ardenne (URCA), Service d'anesthésie - réanimation chirurgicale [CHU Bichat], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Cité (UPCité), Université Paris Cité (UPCité), Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre de référence des maladies héréditaires du métabolisme (MaMEA Nancy-Brabois), Service d'Hépato-gastro-entérologie [CHRU Nancy], Ingénierie Moléculaire et Physiopathologie Articulaire (IMoPA), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Service de Pharmacologie Clinique et Toxicologie [CHRU Nancy], The ALPHO study NCT02250729 was requested and supported by the European Medicines Agency (EMA). It was funded by a consortium of pharmaceutical companies marketing pholcodine (Zambon, Urgo, Les Laboratoires Pierre Fabre, Boots, Hepatoum, Biocodex, Sanofi, Laboratoires Bouchara Recordati, GlaxoSmithKline, Alliance Pharmaceuticals Ltd, Bells Healthcare, Pinewood, T & R, Ernest Jackson, Vemedia)., and ALPHO Study Group: Emmanuelle Aguinet, Pol André Apoil, Jean Eric Autegarden, Faiza Bettayeb, Céline Biermann, Maryline Bordes-Demolis, Anca Chiriac, Pierre Antoine Darene, Frédéric Deblay, Sabrina Dessard, Charles Dzviga, Hassan El Hanache, Alain Facon, Yannick Fuhrer, Noémie Gest, Marion Gouitaa, Adela Harpan, Cyrille Hoarau, Lisa Le Guillou, Laurence Lepeltier, Claire Mailhol, Delphine Mariotte, Yannick Meunier, Isabelle Migueres, Martine Morisset, Catherine Neukirch, Dalila Nouar, Yann Ollivier, Isabelle Orsel, Omar Outtas, Minaxi Patel, Christelle Pellerin, Isabelle Petit, Anaïs Pipet, Cécile Rochefort-Morel, Claire Schwartz, Sandrine Seltzer, Alice Seringulian, Angèle Soria, Lilia Soufir, Rodolphe Stenger, Céline Tummino, Marion Verdaguer
- Subjects
Anesthesiology and Pain Medicine ,[SDV]Life Sciences [q-bio] ,anaphylaxis ,anaesthesia ,quaternary ammonium compounds ,neuromuscular blocking agents ,pholcodine - Abstract
International audience; BackgroundNeuromuscular blocking agents (NMBAs) are among the leading cause of perioperative anaphylaxis, and most of these reactions are IgE mediated. Allergic sensitisation induced by environmental exposure to other quaternary ammonium-containing compounds, such as pholcodine, has been suggested. The aim of this study was to assess the relationship between pholcodine exposure and NMBA-related anaphylaxis.MethodsALPHO was a multicentre case-control study, comparing pholcodine exposure within a year before anaesthesia between patients with NMBA-related perioperative anaphylaxis (cases) and control patients with uneventful anaesthesia in France. Each case was matched to two controls by age, sex, type of NMBA, geographic area, and season. Pholcodine exposure was assessed by a self-administered questionnaire and pharmaceutical history retrieved from pharmacy records. The diagnostic values of anti-pholcodine and anti-quaternary ammonium specific IgE (sIgE) were also evaluated.ResultsOverall, 167 cases were matched with 334 controls. NMBA-related anaphylaxis was significantly associated with pholcodine consumption (odds ratio 4.2; 95% confidence interval 2.3–7.0) and occupational exposure to quaternary ammonium compounds (odds ratio 6.1; 95% confidence interval 2.7–13.6), suggesting that apart from pholcodine, other environmental factors can also lead to sensitisation to NMBAs. Pholcodine and quaternary ammonium sIgEs had a high negative predictive value (99.9%) but a very low positive predictive value (
- Published
- 2023
- Full Text
- View/download PDF
3. NR-fit, on va tous y passer !
- Author
-
Olivier Untereiner, Cédric Basquin, Antonia Blanie, Maryline Bordes, Julien Bordes, Jean-Louis Bourgain, Sébastien Campion, Dominique Fletcher, Régis Fuzier, Estelle Morau, Iris Pelieu, Ludovic Pelligand, Aurélie San Miguel, Lilia Soufir, Alexandre Theissen, Charles-Hervé Vacheron, and Julien Picard
- Subjects
Anesthesiology and Pain Medicine ,Emergency Medicine ,Emergency Nursing - Published
- 2023
- Full Text
- View/download PDF
4. Sédation profonde et continue maintenue jusqu’au décès en réanimation : mise au point de la Commission d’Ethique de la SRLF
- Author
-
Alexandra Laurent, Zoé Cohen-Solal, Jean-Pierre Quenot, Jean Reignier, CE de la Srlf, Raphaëlle David, Thierry Boulain, Régis Quéré, Emmanuelle Mercier, Lilia Soufir, Bertrand Quentin, Olivier Lesieur, Virginie Lemiale, Cyril Goulenok, Bénédicte Gaillard-Le Roux, Laure de Saint-Blanquat, Jean-Philippe Rigaud, Sylvain Lavoué, Mathieu Serie, Benoit Misset, Gwendolyn Penven, Chaouki Mezher, Anne-Laure Poujol, René Robert, and Maxime Elbaz
- Subjects
Intensive care ,Philosophy ,Emergency Medicine ,Emergency Nursing ,Humanities - Abstract
La mise en œuvre de la sédation profonde et continue maintenue jusqu’au décès en réanimation peut s’avérer complexe car il faut tenir compte de la singularité de chaque patient et de son entourage. Cet aspect de la prise en charge devrait être évoqué autant que possible avec le patient et ses proches bien avant que la question de la fin de vie ne se pose. Formation des soignants, information des patients et des proches et adaptation de l’environnement en fin de vie représentent les pistes d’amélioration de la prise en charge de la fin de vie en réanimation.
- Published
- 2021
- Full Text
- View/download PDF
5. Intégration de la démarche palliative à la médecine intensive-réanimation : de la théorie à la pratique
- Author
-
Jean-Philippe Rigaud, Jean-Pierre Quenot, Jean Reignier, Thierry Boulain, S. Rolando, Bertrand Quentin, A. Boyer, B. Eon, Jérôme Pillot, Lilia Soufir, T. Vanderlinden, O. Noizet-Yverneau, L. De Saint-Blanquat, I. Blondiaux, Gwendolyn Penven, Mathieu Serie, S. Dray, Alexandra Laurent, M. C. Jars-Guincestre, F. Bordet, and F. Gonzalez
- Subjects
business.industry ,Emergency Medicine ,Medicine ,Emergency Nursing ,business - Published
- 2019
- Full Text
- View/download PDF
6. Cyberattaque : le nouveau défi pour les établissements de santé ?
- Author
-
Alexandre Theissen, Antonia Blanié, Olivier Untereiner, Maryline Bordes, Dominique Fletcher, Jean Lemarie, Ludovic Pelligand, Lilia Soufir, Frédéric J. Mercier, Régis Fuzier, Julien Bordes, Jean-Louis Bourgain, Charles-Hervé Vacheron, Julien Picard, and Estelle Morau
- Subjects
Anesthesiology and Pain Medicine ,business.industry ,Medicine ,business - Published
- 2021
- Full Text
- View/download PDF
7. Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy
- Author
-
Christophe Adrie, Maité Garrouste-Orgeas, Wafa Ibn Essaied, Carole Schwebel, Michael Darmon, Bruno Mourvillier, Stéphane Ruckly, Anne-Sylvie Dumenil, Hatem Kallel, Laurent Argaud, Guillaume Marcotte, Francois Barbier, Virginie Laurent, Dany Goldgran-Toledano, Christophe Clec'h, Elie Azoulay, Bertrand Souweine, Jean-François Timsit, Yves Cohen, Maïté Garrouste-Orgeas, Lilia Soufir, Alban Le Monnier, Jean-Ralph Zahar, Corinne Alberti, Jean-Francois Timsit, Sebastien Bailly, Cecile Pommier, Wafa Ifn Essaeid, Aurélien Vannieuwenhuyze, Bernard Allaouchiche, Claire Ara-Somohano, Jean-Pierre Bedos, Agnès Bonadona, Anne-Laure Borel, Caroline Bornstain, Lila Bouadma, Alexandre Boyer, Jean-Pierre Colin, Antoine Gros, Rebecca Hamidfar-Roy, Hakim Haouache, Samir Jamali, Alexandre Lautrette, Christian Laplace, Benoit Misset, Laurent Montesino, Benoît Misset, Guillaume Lacave, Virgine Lemiale, Eric Marriotte, Benjamin Planquette, Jean Reignier, Romain Sonneville, Gilles Troché, Marie Thuong, Eric Vantalon, Caroline Tournegros, Loïc Ferrand, Nadira Kaddour, Boris Berthe, Kaouttar Mellouk, Sophie Letrou, Igor Théodose, Julien Fournier, Véronique Deiler, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Institut National de la Recherche Agronomique (INRA)
- Subjects
Male ,0301 basic medicine ,Databases, Factual ,[SDV]Life Sciences [q-bio] ,Bacteremia ,Antimicrobial therapy ,law.invention ,antibiotic-therapy ,0302 clinical medicine ,Risk Factors ,law ,Drug Resistance, Multiple, Bacterial ,030212 general & internal medicine ,risk-factors ,Outcome ,Cross Infection ,pseudomonas-aeruginosa ,critically-ill patients ,Mortality rate ,Hazard ratio ,gram-negative bacteremia ,Middle Aged ,Antimicrobial ,Intensive care unit ,Anti-Bacterial Agents ,3. Good health ,Intensive Care Units ,Treatment Outcome ,Infectious Diseases ,Female ,France ,Fluoroquinolones ,Microbiology (medical) ,medicine.medical_specialty ,Combination therapy ,030106 microbiology ,Bloodstream infection ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,intensive-care-unit ,matched cohort ,Intensive care medicine ,Aged ,combination ,Proportional hazards model ,business.industry ,organ dysfunction ,Pneumonia ,medicine.disease ,severe sepsis ,Multiple drug resistance ,Aminoglycosides ,septic shock ,Nosocomial ,business - Abstract
International audience; Objectives: ICU-acquired bloodstream infection (ICU-BSI) in Intensive Care unit (ICU) is still associated with a high mortality rate. The increase of antimicrobial drug resistance makes its treatment increasingly challenging. Methods: We analyzed 571 ICU-BSI occurring amongst 10,734 patients who were prospectively included in the Outcomerea Database and who stayed at least 4 days in ICU. The hazard ratio of death associated with ICU-BSI was estimated using a multivariate Cox model adjusted on case mix, patient severity and daily SOFA. Results: ICU-BSI was associated with increased mortality (HR, 1.40; 95% CI, 1.16-1.69; p = 0.0004). The relative increase in the risk of death was 130% (HR, 2.3; 95% CI, 1.8-3.0) when initial antimicrobial agents within a day of ICU-BSI onset were not adequate, versus only 20% (HR, 1.2; 95% CI, 0.9-1.5) when an adequate therapy was started within a day. The adjusted hazard ratio of death was significant overall, and even higher when the ICU-BSI source was pneumonia or unknown origin. When treated with appropriate antimicrobial agents, the death risk increase was similar for ICU-BSI due to multidrug resistant pathogens or susceptible ones. Interestingly, combination therapy with a fluoroquinolone was associated with more favorable outcome than monotherapy, whereas combination with aminoglycoside was associated with similar mortality than monotherapy. Conclusions: ICU-BSI was associated with a 40% increase in the risk of 30-day mortality, particularly if the early antimicrobial therapy was not adequate. Adequacy of antimicrobial therapy, but not pathogen resistance pattern, impacted attributable mortality. (C) 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
- Published
- 2017
- Full Text
- View/download PDF
8. A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia
- Author
-
Stéphane Ruckly, Jean-François Timsit, Laurent Argaud, Carole Schwebel, Lila Bouadma, Michael Darmon, Maité Garrouste-Orgeas, Shidasp Siami, Yves Cohen, Hatem Kallel, Guillaume Marcotte, Lilia Soufir, Dany Glodgran-Toledano, Bertrand Souweine, Laurent Papazian, Wafa Ibn Saied, Bruno Mourvillier, Etienne de Montmollin, Jean Reignier, Neuropsychopharmacologie, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Pierre et Marie Curie - Paris 6 (UPMC), Service de Réanimation Médicale, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France, parent, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), Laboratoire Microorganismes : Génome et Environnement (LMGE), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Centre National de la Recherche Scientifique (CNRS), Aix Marseille Université (AMU), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Physique du Globe de Paris (IPGP), Institut national des sciences de l'Univers (INSU - CNRS)-IPG PARIS-Université Paris Diderot - Paris 7 (UPD7)-Université de La Réunion (UR)-Centre National de la Recherche Scientifique (CNRS), Université Paris Diderot - Paris 7 (UPD7), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Centre National de la Recherche Scientifique (CNRS)-Université de La Réunion (UR)-Université Paris Diderot - Paris 7 (UPD7)-IPG PARIS-Institut national des sciences de l'Univers (INSU - CNRS), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), and Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Centre National de la Recherche Scientifique (CNRS)-Université d'Auvergne - Clermont-Ferrand I (UdA)
- Subjects
Male ,medicine.medical_specialty ,Organ Dysfunction Scores ,health care facilities, manpower, and services ,[SDV]Life Sciences [q-bio] ,Critical Care and Intensive Care Medicine ,03 medical and health sciences ,0302 clinical medicine ,Pharmacotherapy ,Risk Factors ,medicine ,Pneumonia, Bacterial ,Humans ,Hospital Mortality ,Prospective Studies ,Simplified Acute Physiology Score ,Prospective cohort study ,Aged ,Proportional Hazards Models ,Cross Infection ,Proportional hazards model ,business.industry ,Ventilator-associated pneumonia ,Bacterial pneumonia ,Pneumonia, Ventilator-Associated ,030208 emergency & critical care medicine ,Middle Aged ,medicine.disease ,3. Good health ,respiratory tract diseases ,Pneumonia ,Intensive Care Units ,030228 respiratory system ,Emergency medicine ,Female ,France ,Risk assessment ,business - Abstract
International audience; OBJECTIVES: To investigate the respective impact of ventilator-associated pneumonia and ICU-hospital-acquired pneumonia on the 30-day mortality of ICU patients. DESIGN: Longitudinal prospective studies. SETTING: French ICUs. PATIENTS: Patients at risk of ventilator-associated pneumonia and ICU-hospital-acquired pneumonia. INTERVENTIONS: The first three episodes of ventilator-associated pneumonia or ICU-hospital-acquired pneumonia were handled as time-dependent covariates in Cox models. We adjusted using the case-mix, illness severity, Simplified Acute Physiology Score II score at admission, and procedures and therapeutics used during the first 48 hours before the risk period. Baseline characteristics of patients with regard to the adequacy of antibiotic treatment were analyzed, as well as the Sequential Organ Failure Assessment score variation in the 2 days before the occurrence of ventilator-associated pneumonia or ICU-hospital-acquired pneumonia. Mortality was also analyzed for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species(ESKAPE) and P. aeruginosa pathogens. MEASUREMENTS AND MAIN RESULTS: Of 14,212 patients who were admitted to the ICUs and who stayed for more than 48 hours, 7,735 were at risk of ventilator-associated pneumonia and 9,747 were at risk of ICU-hospital-acquired pneumonia. Ventilator-associated pneumonia and ICU-hospital-acquired pneumonia occurred in 1,161 at-risk patients (15%) and 176 at-risk patients (2%), respectively. When adjusted on prognostic variables, ventilator-associated pneumonia (hazard ratio, 1.38 (1.24-1.52); p \textless 0.0001) and even more ICU-hospital-acquired pneumonia (hazard ratio, 1.82 [1.35-2.45]; p \textless 0.0001) were associated with increased 30-day mortality. The early antibiotic therapy adequacy was not associated with an improved prognosis, particularly for ICU-hospital-acquired pneumonia. The impact was similar for ventilator-associated pneumonia and ICU-hospital-acquired pneumonia mortality due to P. aeruginosa and the ESKAPE group. CONCLUSIONS: In a large cohort of patients, we found that both ICU-hospital-acquired pneumonia and ventilator-associated pneumonia were associated with an 82% and a 38% increase in the risk of 30-day mortality, respectively. This study emphasized the importance of preventing ICU-hospital-acquired pneumonia in nonventilated patients.
- Published
- 2019
- Full Text
- View/download PDF
9. Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation
- Author
-
Eric Kipnis, Emmanuelle Mercier, Xavier Forceville, Maité Garrouste-Orgeas, Antoine Rouget, Yannick Monseau, Julio Badie, Stéphane Ruckly, Georges Simon, Isabelle Vinatier, Sébastien Bailly, Lilia Soufir, Lucie Bellalou, Jean-Philippe Rigaud, Olfa Hamzaoui, Marina Thirion, Olivier Lesieur, Virginie Maxime, Nora Amdjar-Badidi, Benoit Misset, Laurent Argaud, Sandrine Valade, Paul-Henri Jost, Cécile Flahault, Alexandre Lautrette, Anne Renault, Rebecca Hamidfar, Mercé Jourdain, Marie Annick Leborgne, Léonor Fasse, Lila Bouadma, Audrey Large, François Santoli, Jean-Paul Mira, Bernard Floccard, Christel Vioulac, Nathalie Thieulot-Rolin, Naïke Bigé, Erika Parmentier-Decrucq, Eric Boulet, Fabienne Tamion, Hubert Grand, Alain Gaffinel, Jean-François Timsit, and Cédric Bretonnière
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Hospital Anxiety and Depression Scale ,01 natural sciences ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Interquartile range ,Internal medicine ,medicine ,030212 general & internal medicine ,0101 mathematics ,Depression (differential diagnoses) ,Original Investigation ,Mechanical ventilation ,business.industry ,Minimal clinically important difference ,010102 general mathematics ,General Medicine ,Intensive care unit ,3. Good health ,Anxiety ,medicine.symptom ,business - Abstract
Importance Keeping a diary for patients while they are in the intensive care unit (ICU) might reduce their posttraumatic stress disorder (PTSD) symptoms. Objectives To assess the effect of an ICU diary on the psychological consequences of an ICU hospitalization. Design, Setting, and Participants Assessor-blinded, multicenter, randomized clinical trial in 35 French ICUs from October 2015 to January 2017, with follow-up until July 2017. Among 2631 approached patients, 709 adult patients (with 1 family member each) who received mechanical ventilation within 48 hours after ICU admission for at least 2 days were eligible, 657 were randomized, and 339 were assessed 3 months after ICU discharge. Interventions Patients in the intervention group (n = 355) had an ICU diary filled in by clinicians and family members. Patients in the control group (n = 354) had usual ICU care without an ICU diary. Main Outcomes and Measures The primary outcome was significant PTSD symptoms, defined as an Impact Event Scale-Revised (IES-R) score greater than 22 (range, 0-88; a higher score indicates more severe symptoms), measured in patients 3 months after ICU discharge. Secondary outcomes, also measured at 3 months and compared between groups, included significant PTSD symptoms in family members; significant anxiety and depression symptoms in patients and family members, based on a Hospital Anxiety and Depression Scale score greater than 8 for each subscale (range, 0-42; higher scores indicate more severe symptoms; minimal clinically important difference, 2.5); and patient memories of the ICU stay, reported with the ICU memory tool. Results Among 657 patients who were randomized (median [interquartile range] age, 62 [51-70] years; 126 women [37.2%]), 339 (51.6%) completed the trial. At 3 months, significant PTSD symptoms were reported by 49 of 164 patients (29.9%) in the intervention group vs 60 of 175 (34.3%) in the control group (risk difference, −4% [95% CI, −15% to 6%];P = .39). The median (interquartile range) IES-R score was 12 (5-25) in the intervention group vs 13 (6-27) in the control group (difference, −1.47 [95% CI, −1.93 to 4.87];P = .38). There were no significant differences in any of the 6 prespecified comparative secondary outcomes. Conclusions and Relevance Among patients who received mechanical ventilation in the ICU, the use of an ICU diary filled in by clinicians and family members did not significantly reduce the number of patients who reported significant PTSD symptoms at 3 months. These findings do not support the use of ICU diaries for preventing PTSD symptoms. Trial Registration ClinicalTrials.gov Identifier:NCT02519725
- Published
- 2019
- Full Text
- View/download PDF
10. Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group
- Author
-
Samir Jamali, Maité Garrouste-Orgeas, Lilia Soufir, Muriel Fartoukh, Michael Darmon, Guillaume Marcotte, Jean-François Timsit, Carole Schwebel, Bruno Verdière, Dany Golgran-Toledano, C Grégoire, Anne-Sylvie Dumesnil, Stéphane Ruckly, Christophe Clec’h, Laurent Argaud, Cecile Pommier, Elie Azoulay, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Institut National de la Recherche Agronomique (INRA)
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,Critical Care and Intensive Care Medicine ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Elderly ,law ,Internal medicine ,Anesthesiology ,Severity of illness ,medicine ,80 and over ,Intensive care unit ,030212 general & internal medicine ,Renal replacement therapy ,business.industry ,Research ,030208 emergency & critical care medicine ,Triage ,3. Good health ,Blood pressure ,Multicenter study ,Emergency medicine ,End of life ,Observational study ,business - Abstract
Background Outcome of very elderly patients admitted in intensive care unit (ICU) was most often reported for octogenarians. ICU admission demands for nonagenarians are increasing. The primary objective was to compare outcome and intensity of treatment of octogenarians and nonagenarians. Methods We performed an observational study in 12 ICUs of the Outcomerea™ network which prospectively upload data into the Outcomerea™ database. Patients >90 years old (case patients) were matched with patients 80–90 years old (control patients). Matching criteria were severity of illness at admission, center, and year of admission. Results A total of 2419 patients aged 80 or older and admitted from September 1997 to September 2013 were included. Among them, 179 (7.9 %) were >90 years old. Matching was performed for 176 nonagenarian patients. Compared with control patients, case patients were more often hospitalized for unscheduled surgery [54 (30.7 %) vs. 42 (23.9 %), p
- Published
- 2016
- Full Text
- View/download PDF
11. Prise en charge des thrombopénies en réanimation (pathologies gravidiques exclues). Recommandations formalisées d’experts sous l’égide de la Société de réanimation de langue française (SRLF), avec la participation du Groupe francophone de réanimation et urgences pédiatriques (GFRUP) et du Groupe d’étude hémostase thrombose (GEHT) de la Société française d’hématologie (SFH)
- Author
-
pour le groupe d’experts, T. Van der Linden, Lilia Soufir, P. Meyer, Bertrand Souweine, and Laurent Dupic
- Subjects
Emergency Medicine ,Emergency Nursing - Published
- 2011
- Full Text
- View/download PDF
12. Impact of adverse events on outcomes in intensive care unit patients*
- Author
-
Maite, Garrouste Orgeas, Jean Francois, Timsit, Lilia, Soufir, Muriel, Tafflet, Christophe, Adrie, Francois, Philippart, Jean Ralph, Zahar, Christophe, Clec'h, Dany, Goldran-Toledano, Samir, Jamali, Anne-Sylvie, Dumenil, Elie, Azoulay, Jean, Carlet, Vincent, Willems, Service de réanimation chirurgicale [Béclère], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Antoine Béclère [Clamart], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), INSERM U823, équipe 11 (Epidémiologie des cancers et des affections graves), Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF)-Service de réanimation médicale, Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Service d'anesthesiologie, Hôpital Saint Joseph, Département de biostatistiques, Outcomerea, Service de bactériologie, virologie, parasitologie et hygiène, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Necker - Enfants Malades [AP-HP], Service de réanimation médicale, Vesin, Aurélien, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)-Service de réanimation médicale, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], and Service de bactériologie, virologie, parasitologie et hygiène [CHU Necker]
- Subjects
Male ,Resuscitation ,Databases, Factual ,MESH: Logistic Models ,Critical Care and Intensive Care Medicine ,Severity of Illness Index ,law.invention ,0302 clinical medicine ,law ,Multicenter Studies as Topic ,Medicine ,MESH: Quality of Health Care ,MESH: Incidence ,030212 general & internal medicine ,MESH: Aged ,Cross Infection ,MESH: Middle Aged ,Incidence ,Confounding ,Middle Aged ,MESH: Case-Control Studies ,Intensive care unit ,3. Good health ,Intensive Care Units ,Female ,Cohort study ,medicine.medical_specialty ,03 medical and health sciences ,MESH: Severity of Illness Index ,Intensive care ,Severity of illness ,Humans ,Intensive care medicine ,Adverse effect ,Aged ,Quality of Health Care ,MESH: Humans ,business.industry ,Case-control study ,MESH: Cross Infection ,030208 emergency & critical care medicine ,MESH: Databases, Factual ,MESH: Male ,Logistic Models ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Case-Control Studies ,MESH: Multicenter Studies as Topic ,MESH: Intensive Care Units ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,MESH: Female - Abstract
International audience; OBJECTIVE: To examine the association between predefined adverse events (AE) (including nosocomial infections) and intensive care unit (ICU) mortality, controlling for multiple adverse events in the same patient and confounding variables. DESIGN: Prospective observational cohort study of the French OUTCOMEREA multicenter database. SETTING: Twelve medical or surgical ICUs. PATIENTS: Unselected patients hospitalized for > or = 48 hrs enrolled between 1997 and 2003. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Of the 3,611 patients included, 1415 (39.2%) experienced one or more AEs and 821 (22.7%) had two or more AEs. Mean number of AEs per patient was 2.8 (range, 1-26). Six AEs were associated with death: primary or catheter-related bloodstream infection (BSI) (odds ratio [OR], 2.92; 95% confidence interval [CI], 1.6-5.32), BSI from other sources (OR, 5.7; 95% CI, 2.66-12.05), nonbacteremic pneumonia (OR, 1.69; 95% CI, 1.17-2.44), deep and organ/space surgical site infection without BSI (OR, 3; 95% CI, 1.3-6.8), pneumothorax (OR, 3.1; 95% CI, 1.5-6.3), and gastrointestinal bleeding (OR, 2.6; 95% CI, 1.4-4.9). The results were not changed when the analysis was confined to patients with mechanical ventilation on day 1, intermediate severity of illness (Simplified Acute Physiology Score II between 35 and 55), no treatment-limitation decisions, or no cardiac arrest in the ICU. CONCLUSIONS: AEs were common and often occurred in combination in individual patients. Several AEs independently contributed to death. Creating a safe ICU environment is a challenging task that deserves careful attention from ICU physicians.
- Published
- 2008
- Full Text
- View/download PDF
13. The Iatroref study: medical errors are associated with symptoms of depression in ICU staff but not burnout or safety culture
- Author
-
Pascal Beuret, Virginie Maxime, Elie Azoulay, Kada Klouche, Jean-François Timsit, Aurélien Vesin, Maité Garrouste-Orgeas, Gilles Troché, Marion Perrin, Lilia Soufir, Laurent Argaud, François Blot, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,health care facilities, manpower, and services ,[SDV]Life Sciences [q-bio] ,multicenter ,Burnout ,Critical Care and Intensive Care Medicine ,outcomes ,workload ,0302 clinical medicine ,Surveys and Questionnaires ,Prevalence ,patient safety ,Prospective Studies ,030212 general & internal medicine ,Emotional exhaustion ,Burnout, Professional ,Depression (differential diagnoses) ,Medical Errors ,Depression ,Middle Aged ,3. Good health ,Intensive Care Units ,quality ,Female ,France ,Safety ,intensive-care units ,medicine.medical_specialty ,education ,nurse burnout ,Medical error ,Iatrogenic event ,03 medical and health sciences ,Patient safety ,Iatroref ,Physicians ,General & Internal Medicine ,medicine ,Humans ,Intensive care unit ,Safety culture ,Risk factor ,Adverse effect ,Aged ,business.industry ,030208 emergency & critical care medicine ,mortality ,Emergency medicine ,Observational study ,program ,business ,hospitals - Abstract
International audience; Purpose: Staff behaviours to optimise patient safety may be influenced by burnout, depression and strength of the safety culture. We evaluated whether burnout, symptoms of depression and safety culture affected the frequency of medical errors and adverse events (selected using Delphi techniques) in ICUs. Methods: Prospective, observational, multicentre (31 ICUs) study from August 2009 to December 2011. Results: Burnout, depression symptoms and safety culture were evaluated using the Maslach Burnout Inventory (MBI), CES-Depression scale and Safety Attitudes Questionnaire, respectively. Of 1,988 staff members, 1,534 (77.2 %) participated. Frequencies of medical errors and adverse events were 804.5/1,000 and 167.4/1,000 patient-days, respectively. Burnout prevalence was 3 or 40 % depending on the definition (severe emotional exhaustion, depersonalisation and low personal accomplishment; or MBI score greater than -9). Depression symptoms were identified in 62/330 (18.8 %) physicians and 188/1,204 (15.6 %) nurses/nursing assistants. Median safety culture score was 60.7/100 [56.8-64.7] in physicians and 57.5/100 [52.4-61.9] in nurses/nursing assistants. Depression symptoms were an independent risk factor for medical errors. Burnout was not associated with medical errors. The safety culture score had a limited influence on medical errors. Other independent risk factors for medical errors or adverse events were related to ICU organisation (40 % of ICU staff off work on the previous day), staff (specific safety training) and patients (workload). One-on-one training of junior physicians during duties and existence of a hospital risk-management unit were associated with lower risks. Conclusions: The frequency of selected medical errors in ICUs was high and was increased when staff members had symptoms of depression.
- Published
- 2015
- Full Text
- View/download PDF
14. Excess Risk of Death from Intensive Care Unit--Acquired Nosocomial Bloodstream Infections: A Reappraisal
- Author
-
Elie Azoulay, Samir Jamali, Yves Cohen, Marie-Alliette Costa de Beauregard, Bruno Mourvillier, Christophe Adrie, Adrien Descorps-Declere, Muriel Tafflet, Arnaud de Lassence, T. Lazard, Benoit Misset, Jean Carlet, Maité Garrouste-Orgeas, Christine Cheval, Lilia Soufir, Jean-François Timsit, and Jean-Ralph Zahar
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Pediatrics ,Databases, Factual ,law.invention ,Risk Factors ,law ,Internal medicine ,Intensive care ,Humans ,Medicine ,Risk factor ,Cross Infection ,business.industry ,Incidence (epidemiology) ,Organ dysfunction ,Odds ratio ,bacterial infections and mycoses ,medicine.disease ,Survival Analysis ,Intensive care unit ,Confidence interval ,Intensive Care Units ,Treatment Outcome ,Infectious Diseases ,Bacteremia ,Calibration ,France ,medicine.symptom ,business ,human activities - Abstract
Overall rates of bloodstream infection (BSI) are often used as quality indicators in intensive care units (ICUs). We investigated whether ICU-acquired BSI increased mortality (byor = 10%) after adjustment for severity of infection at ICU admission and during the pre-BSI stay.We conducted a matched, risk-adjusted (1:n), exposed-unexposed study of patients with stays longer than 72 h in 12 ICUs randomly selected from the Outcomerea database.Patients with BSI after the third ICU day (exposed group) were matched on the basis of risk-exposure time and mortality predicted at admission using the Three-Day Recalibrated ICU Outcome (TRIO) score to patients without BSI (unexposed group). Severity was assessed daily using the Logistic Organ Dysfunction (LOD) score. Of 3247 patients with ICU stays of3 days, 232 experienced BSI by day 30 (incidence, 6.8 cases per 100 admissions); among them, 226 patients were matched to 1023 unexposed patients. Crude hospital mortality was 61.5% among exposed and 36.7% among unexposed patients (P.0001). Attributable mortality was 24.8%. The only variable associated with both BSI and hospital mortality was the LOD score determined 4 days before onset of BSI (odds ratio [OR], 1.10; 95% confidence interval [CI], 1.03-1.16; P = .0025). The adjusted OR for hospital mortality among exposed patients (OR, 3.20; 95% CI, 2.30-4.43) decreased when the LOD score determined 4 days before onset of BSI was taken into account (OR, 3.02; 95% CI, 2.17-4.22; P.0001). The estimated risk of death from BSI varied considerably according to the source and resistance of organisms, time to onset, and appropriateness of treatment.When adjusted for risk-exposure time and severity at admission and during the ICU stay, BSI was associated with a 3-fold increase in mortality, but considerable variation occurred across BSI subgroups. Focusing on BSI subgroups may be valuable for assessing quality of care in ICUs.
- Published
- 2006
- Full Text
- View/download PDF
15. Impact of Humidification Systems on Ventilator-associated Pneumonia
- Author
-
Laurent Brochard, Charles Cerf, Andry Van de Louw, Yves Rebufat, Christian Brun-Buisson, Saïda Rezaiguia, Lilia Soufir, Jean Claude Lacherade, Marc Auburtin, François Lellouche, and Jean-Damien Ricard
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Hot Temperature ,medicine.medical_treatment ,Critical Care and Intensive Care Medicine ,law.invention ,Randomized controlled trial ,Risk Factors ,law ,Multicenter trial ,Intensive care ,Intubation, Intratracheal ,medicine ,Humans ,Mechanical ventilation ,business.industry ,Respiratory disease ,Humidity ,Humidifiers ,Pneumonia ,medicine.disease ,Respiration, Artificial ,Surgery ,Logistic Models ,Heat and moisture exchanger ,Anesthesia ,Multivariate Analysis ,business ,Filtration - Abstract
The respective influence on the incidence of ventilator-associated pneumonia of currently available systems used for warming and humidifying the gases delivered to mechanically ventilated patients, that is, heated humidifiers and heat and moisture exchanger filters, remains controversial.We addressed this question in a multicenter randomized study comparing heated humidifiers (with heated circuits) and filters in an unselected population of 369 intensive care patients receiving mechanical ventilation for more than 48 h.The diagnosis of pneumonia was confirmed according to strict microbiologic criteria. There was no difference in pneumonia rate between the two groups (53 of 184 [28.8%] versus 47 of 185 [25.4%] for humidifiers versus filters; p = 0.48), or in the incidence density of pneumonia (27.4/1,000 ventilatory days versus 25.3/1,000 ventilatory days for humidifiers versus filters; p = 0.76). The mean duration of mechanical ventilation did not differ between the two groups (14.9 +/- 15.1 versus 13.5 +/- 16.3 days for humidifiers versus filters, p = 0.36). Endotracheal tube occlusion occurred, respectively, in five patients and one patient in the humidifier and filter groups (p = 0.12). Intensive care mortality was identical in the two groups (about 33%).These results suggest that both heated humidifiers and heat and moisture exchanger filters can be used with no significant impact on the incidence of ventilator-associated pneumonia and that other criteria may justify their choice.
- Published
- 2005
- Full Text
- View/download PDF
16. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation
- Author
-
Georges Offenstadt, Agnès Lillo-Le Louët, Meyer-Michel Samama, Anne-Sylvie Dumenil, Lilia Soufir, Arnaud Galbois, and Martine Wolf
- Subjects
Resuscitation ,medicine.medical_specialty ,Erythrocyte transfusion ,Fatal outcome ,business.industry ,medicine.medical_treatment ,Vascular biology ,Hematology ,030204 cardiovascular system & hematology ,medicine.disease ,Thrombosis ,Surgery ,Dabigatran ,03 medical and health sciences ,0302 clinical medicine ,Emergency surgery ,Emergency medicine ,Medicine ,030212 general & internal medicine ,business ,medicine.drug ,Colectomy - Abstract
Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: Implications for emergency surgery and resuscitation
- Published
- 2012
- Full Text
- View/download PDF
17. Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study
- Author
-
Anne-Sylvie Dumenil, Maité Garrouste-Orgeas, Carole Schwebel, Elie Azoulay, Romain Sonneville, Lilia Soufir, Bertrand Souweine, Laurent Argaud, Christophe Adrie, Virginie Laurent, Guillaume Marcotte, Jean Reignier, Christophe Clec’h, Anne-Laure Borel, Dany Goldgran-Toledano, Michael Darmon, Hakim Haouache, Stéphane Ruckly, Jean-François Timsit, Medical-Surgical Intensive Care Unit, Service de Réanimation Médicale [Grenoble], Hôpital Michallon-CHU Grenoble, Hôpital Bichat - Claude Bernard, Laboratoire Microorganismes : Génome et Environnement (LMGE), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Université d'Auvergne - Clermont-Ferrand I (UdA)-Centre National de la Recherche Scientifique (CNRS), Hôpital Delafontaine, Centre Hospitalier de Saint-Denis [Ile-de-France], Laboratoire de Neurosciences Intégratives et Cliniques - UFC (EA 481) (NEURO), Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Service d'anesthesiologie, Hôpital Saint Joseph, LIPHY-DYFCOM, Laboratoire Interdisciplinaire de Physique [Saint Martin d’Hères] (LIPhy), Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS), Service de Réanimation Polyvalente, Centre Hospitalier de Gonesse, Université Paris Diderot - Paris 7 (UPD7), Service de réanimation médicale, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Grenoble-Hôpital Michallon, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Université Sorbonne Paris Cité (USPC), Service de Réanimation Médicale, CHU Grenoble-Hôpital Albert Michallon, Laboratoire Microorganismes : Génome et Environnement ( LMGE ), Université Blaise Pascal - Clermont-Ferrand 2 ( UBP ) -Université d'Auvergne - Clermont-Ferrand I ( UdA ) -Centre National de la Recherche Scientifique ( CNRS ), Laboratoire Traitement du Signal et de l'Image ( LTSI ), Université de Rennes 1 ( UR1 ), Université de Rennes ( UNIV-RENNES ) -Université de Rennes ( UNIV-RENNES ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Centre Hospitalier de Saint-Denis, Laboratoire de Neurosciences Intégratives et Cliniques - UFC ( NEURO ), Université Bourgogne Franche-Comté ( UBFC ) -Université de Franche-Comté ( UFC ), Laboratoire Interdisciplinaire de Physique [Saint Martin d’Hères] ( LIPhy ), Université Joseph Fourier - Grenoble 1 ( UJF ) -Centre National de la Recherche Scientifique ( CNRS ) -Université Joseph Fourier - Grenoble 1 ( UJF ) -Centre National de la Recherche Scientifique ( CNRS ), Université Paris Diderot - Paris 7 ( UPD7 ), Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ) -Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Infection, Antimicrobiens, Modélisation, Evolution ( IAME ), Université Paris 13 ( UP13 ) -Université Paris Diderot - Paris 7 ( UPD7 ) -Université Sorbonne Paris Cité ( USPC ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Blaise Pascal - Clermont-Ferrand 2 (UBP)-Centre National de la Recherche Scientifique (CNRS)-Université d'Auvergne - Clermont-Ferrand I (UdA), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université de Franche-Comté (UFC), Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Université Joseph Fourier - Grenoble 1 (UJF)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA)-Université Joseph Fourier - Grenoble 1 (UJF), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Laboratoire de Neurosciences Intégratives et Cliniques - UFC (UR 481) (NEURO), DYnamique des Fluides COmplexes et Morphogénèse [Grenoble] (DYFCOM-LIPhy), and Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])
- Subjects
Adult ,Male ,Parenteral Nutrition ,medicine.medical_specialty ,Time Factors ,Calorie ,medicine.medical_treatment ,Nutritional Status ,Critical Care and Intensive Care Medicine ,Enteral administration ,03 medical and health sciences ,Enteral Nutrition ,0302 clinical medicine ,[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathology ,Internal medicine ,Humans ,Medicine ,Prospective Studies ,030212 general & internal medicine ,Mortality ,Prospective cohort study ,Aged ,Proportional Hazards Models ,Mechanical ventilation ,business.industry ,Pneumonia, Ventilator-Associated ,Shock ,Middle Aged ,Respiration, Artificial ,Confidence interval ,3. Good health ,Surgery ,Treatment Outcome ,Parenteral nutrition ,Blood pressure ,030228 respiratory system ,Shock (circulatory) ,Female ,medicine.symptom ,business ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology - Abstract
International audience; Few data are available about optimal nutrition modalities in mechanically ventilated patients with shock. Our objective was to assess associations linking early nutrition (72 h and shock (arterial systolic pressure
- Published
- 2015
- Full Text
- View/download PDF
18. Routine exploratory thoracentesis in ICU patients with pleural effusions: Results of a French questionnaire study
- Author
-
Thomas Similowski, Muriel Fartoukh, Sylvie Chevret, Benoît Schlemmer, Elie Azoulay, Richard Galliot, Lilia Soufir, and Jean-Roger Le Gall
- Subjects
medicine.medical_specialty ,Critical Care ,Attitude of Health Personnel ,Pleural effusion ,medicine.medical_treatment ,Thoracentesis ,Critical Care and Intensive Care Medicine ,Subspecialty ,law.invention ,law ,Surveys and Questionnaires ,Epidemiology ,Humans ,Medicine ,Practice Patterns, Physicians' ,Intensive care medicine ,Pulmonologists ,business.industry ,Incidence (epidemiology) ,Health services research ,Thoracic Surgical Procedures ,medicine.disease ,Intensive care unit ,Pleural Effusion ,Intensive Care Units ,France ,Health Services Research ,business - Abstract
Purpose: The purpose of this study was to report the opinions of intensivists regarding pleural effusions in patients in the intensive care unit (ICU). Materials and Methods: Questionnaires were sent to 1,032 intensivists, who were members of the French Society of Critical Care. Results: Four hundred thirty-one questionnaires (41.7%) were returned. Overall, the respondents' estimated the incidence of pleural effusion in ICU patients to be 22.19 ± 17%, whereas 37 ± 27% considered that exploratory thoracentesis was likely to determine the cause of the effusion, and 17.36 ± 16% considered that its results were likely to result in a change in their therapeutic attitude. Sixty-five (15%) physicians, chiefly pulmonologists, performed exploratory thoracentesis routinely (Group 1). Compared with those who did not perform routine thoracentesis (Group 2), they ascribed a higher proportion of pleural effusions to infection (31.3% vs. 13.5%) and were more likely to consider that exploratory thoracentesis had a diagnostic and therapeutic contribution (51.2% vs. 34% and 23% vs. 16%, respectively). In addition to the respiratory medicine subspecialty, the practice of routine exploratory thoracentesis was significantly related to seniority, to the frequency of the suspicion of an infectious cause in the physician's practice, and to his or her appreciation of the risks associated with exploratory thoracentesis. Physicians from Group 1 were also more likely to describe exploratory thoracentesis as a noninvasive procedure. Conclusions: The beliefs and attitudes of intensivists regarding pleural effusions and exploratory thoracentesis are divergent. This may be due to the lack of precise guidelines on the topic and prompt the design of further studies to establish precisely the epidemiology and causes of pleural effusions in ICU patients. Copyright © 2001 by W.B. Saunders Company
- Published
- 2001
- Full Text
- View/download PDF
19. Changing use of intensive care for hematological patients
- Author
-
Christian Recher, Jean-Paul Fermand, J. R. Le Gall, Elie Azoulay, G. Leleu, Lilia Soufir, Corinne Alberti, and Benoit Schlemmer
- Subjects
Adult ,Male ,Paris ,medicine.medical_specialty ,medicine.medical_treatment ,Critical Care and Intensive Care Medicine ,Severity of Illness Index ,Medical Records ,law.invention ,Hospitals, University ,Patient Admission ,Sex Factors ,law ,Internal medicine ,Anesthesiology ,Intensive care ,Severity of illness ,Humans ,Medicine ,Intensive care medicine ,Dialysis ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Mortality rate ,Retrospective cohort study ,Middle Aged ,Respiration, Artificial ,Intensive care unit ,Intensive Care Units ,Logistic Models ,SAPS II ,Female ,Multiple Myeloma ,business - Abstract
Objective: Intensivists generally view patients with hematological malignancies as poor candidates for intensive care. Nevertheless, hematologists have recently developed more aggressive treatment protocols capable of achieving prolonged complete remissions in many of these patients. This change mandates a reappraisal of indications for ICU admission in each type of hematological disease. Improved knowledge of the prognosis is of assistance in making treatment decisions. Patients and methods: The records of 75 myeloma patients consecutively admitted to our ICU between 1992 and 1998 were reviewed retrospectively and predictors of 30-day mortality were identified using stepwise logistic regression. Results: The median age was 56 years (37–84). Chronic health status (Knaus scale) was C or D in 39 cases. Fifty-five patients (73 %) had stage III disease and 17 had a complete or partial remission. Autologous bone marrow transplantation had been performed in 28 patients (37 %). ICU admission occurred between 1992 and 1995 in 41 patients (54.7 %), and between 1996 and 1998 in 34 patients (45.3 %). The median SAPS II and LOD scores were 60 (23–107) and 7 (0–21), respectively. Reasons for ICU admission were acute respiratory failure in 39 patients (52 %) and shock in 31 (41 %). Forty-six patients (61 %) required mechanical ventilation. Fifty patients (66 %) received vasopressors and 24 dialysis. Thirty-day mortality was 57 %. Only five parameters were independently associated with 30-day mortality in the multivariate model: female gender (OR = 5.12), mechanical ventilation (OR = 16.7) and use of vasopressor agents (OR = 5.67) were associated with a higher mortality rate, whereas disease remission (OR = 0.16) and ICU admission between 1996 and 1998 (OR = 0.09) were associated with a lower one. Conclusion: The prognosis for myeloma patients in the ICU is improving over time. This may reflect either recent therapeutic changes in hematological departments and ICUs or changes in patient selection for ICU admission. Hematologists and intensivists should work closely together to select hematological patients likely to benefit from ICU admission.
- Published
- 1999
- Full Text
- View/download PDF
20. A multifaceted program for improving quality of care in intensive care units: IATROREF study
- Author
-
Maite, Garrouste-Orgeas, Lilia, Soufir, Alexis, Tabah, Carole, Schwebel, Aurelien, Vesin, Christophe, Adrie, Marie, Thuong, Jean Francois, Timsit, and Caroline, Tournegros
- Subjects
Program evaluation ,Male ,medicine.medical_specialty ,Catheterization, Central Venous ,Safety Management ,Quality management ,Critical Care ,Quality Assurance, Health Care ,Critical Illness ,Hospitals, Community ,Critical Care and Intensive Care Medicine ,Risk Assessment ,law.invention ,Hospitals, University ,Patient safety ,Randomized controlled trial ,law ,Intensive care ,Health care ,medicine ,Confidence Intervals ,Intubation, Intratracheal ,Cluster Analysis ,Humans ,Medication Errors ,Hospital Mortality ,Medical prescription ,Intensive care medicine ,Aged ,Medical Errors ,business.industry ,Anticoagulants ,Length of Stay ,Middle Aged ,Intensive care unit ,Quality Improvement ,Intensive Care Units ,Female ,Patient Safety ,business ,Program Evaluation - Abstract
To test the effects of three multifaceted safety programs designed to decrease insulin administration errors, anticoagulant prescription and administration errors, and errors leading to accidental removal of endotracheal tubes and central venous catheters, respectively. Medical errors and adverse events are associated with increased mortality in intensive care patients, indicating an urgent need for prevention programs.Multicenter cluster-randomized study.One medical intensive care unit in a university hospital and two medical-surgical intensive care units in community hospitals belonging to the Outcomerea Study Group.Consecutive patients18 yrs admitted from January 2007 to January 2008 to the intensive care units.We tested three multifaceted safety programs vs. standard care in random order, each over 2.5 months, after a 1.5-month observation period.Incidence rates of medical errors/1000 patient-days in the multifaceted safety program and standard-care groups were compared using adjusted hierarchical models. In 2117 patients with 15,014 patient-days, 8520 medical errors (567.5/1000 patient-days) were reported, including 1438 adverse events (16.9%, 95.8/1000 patient-days). The insulin multifaceted safety program significantly decreased errors during implementation (risk ratio 0.65; 95% confidence interval [CI] 0.52-0.82; p = .0003) and after implementation (risk ratio 0.51; 95% CI 0.35-0.73; p = .0004). A significant Hawthorne effect was found. The accidental tube/catheter removal multifaceted safety program decreased errors significantly during implementation (odds ratio [OR] 0.34; 95% CI 0.15-0.81; p = .01]) and nonsignificantly after implementation (OR 1.65; 95% CI 0.78-3.48). The anticoagulation multifaceted safety program was not significantly effective (OR 0.64; 95% CI 0.26-1.59) but produced a significant Hawthorne effect.A multifaceted program was effective in preventing insulin errors and accidental tube/catheter removal. Significant Hawthorne effects occurred, emphasizing the need for appropriately designed studies before definitively implementing strategies.clinicaltrials.gov Identifier: NCT00461461.
- Published
- 2011
21. A model to predict short-term death or readmission after intensive care unit discharge
- Author
-
Maité Garrouste-Orgeas, Benoit Misset, Jean-François Timsit, Cédric Bruel, Aurélien Vesin, Islem Ouanes, François Philippart, Christophe Adrie, Carole Schwebel, Adrien Français, and Lilia Soufir
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Critical Care and Intensive Care Medicine ,Patient Readmission ,law.invention ,law ,Risk Factors ,medicine ,Health Status Indicators ,Humans ,Hospital Mortality ,Simplified Acute Physiology Score ,Intensive care medicine ,Aged ,Retrospective Studies ,Receiver operating characteristic ,business.industry ,Age Factors ,Retrospective cohort study ,Length of Stay ,Middle Aged ,medicine.disease ,Prognosis ,Intensive care unit ,Confidence interval ,Systemic inflammatory response syndrome ,Intensive Care Units ,SAPS II ,Emergency medicine ,business ,Central venous catheter - Abstract
Objective Early unplanned readmission to the intensive care unit (ICU) carries a poor prognosis, and post-ICU mortality may be related, in part, to premature ICU discharge. Our objectives were to identify independent risk factors for early post-ICU readmission or death and to construct a prediction model. Design Retrospective analysis of a prospective database was done. Setting Four ICUs of the French Outcomerea network participated. Patients Patients were consecutive adults with ICU stay longer than 24 hours who were discharged alive to same-hospital wards without treatment-limitation decisions. Main results Of 5014 admitted patients, 3462 met our inclusion criteria. Age was 60.6 ± 17.6 years, and admission Simplified Acute Physiology Score II (SAPS II) was 35.1 ± 15.1. The rate of death or ICU readmission within 7 days after ICU discharge was 3.0%. Independent risk factors for this outcome were age, SAPS II at ICU admission, use of a central venous catheter in the ICU, Sepsis-related Organ Failure Assessment and Systemic Inflammatory Response Syndrome scores before ICU discharge, and discharge at night. The predictive model based on these variables showed good calibration. Compared with SAPS II at admission or Stability and Workload Index for Transfer at discharge, discrimination was better with our model (area under receiver operating characteristics curve, 0.74; 95% confidence interval, 0.68-0.79). Conclusion Among patients without treatment-limitation decisions and discharged alive from the ICU, 3.0% died or were readmitted within 7 days. Independent risk factors were indicators of patients' severity and discharge at night. Our prediction model should be evaluated in other ICU populations.
- Published
- 2011
22. [Anaesthesia in elderly people]
- Author
-
Virginie, Laurent, Paer-Selim, Abback, Pascal, Christian, Nze, Obiang, Lilia, Soufir, and Isabelle, Rouquette-Vincenti
- Subjects
Aged, 80 and over ,Male ,Cause of Death ,Patient Selection ,Humans ,Anesthesia ,Female ,Comorbidity ,France ,Geriatric Assessment ,Risk Assessment ,Perioperative Care ,Aged - Abstract
The "perioperative" period for elderly patients is prone to a significant level of morbidity and mortality. Chronological age and comorbidities are the main causes of mortality. Loco-regional anaesthesia is used in 50% of cases. When general anaesthesia is used, invasive monitoring is the rule, with titration of medication and pain treatment. Cognitive dysfunctions are related to age rather than the anaesthetic technique. The aim is for early rehabilitation perhaps through ambulatory care.
- Published
- 2011
23. Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II
- Author
-
Maité, Garrouste-Orgeas, Jean François, Timsit, Aurelien, Vesin, Carole, Schwebel, Patrick, Arnodo, Jean Yves, Lefrant, Bertrand, Souweine, Alexis, Tabah, Julien, Charpentier, Olivier, Gontier, Fabienne, Fieux, Bruno, Mourvillier, Gilles, Troché, Jean, Reignier, Marie Françoise, Dumay, Elie, Azoulay, Bernard, Reignier, Jean, Carlet, Lilia, Soufir, B, Souweine, Réanimation Médico-Chirurgicale, Groupe Hospitalier Paris Saint-Joseph, Institut d'oncologie/développement Albert Bonniot de Grenoble (INSERM U823), Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF), INSERM U823, équipe 11 (Epidémiologie des cancers et des affections graves), Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM)-EFS-CHU Grenoble-Université Joseph Fourier - Grenoble 1 (UJF)-Département de biostatistiques, Outcomerea-Outcomerea-Clinique de réanimation médicale, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-Hôpital Michallon-Hôpital Michallon, Département de biostatistiques, Outcomerea, Clinique de réanimation médicale, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-Hôpital Michallon, Réanimation médico-chirurgicale, Centre Hospitalier du Pays d'Aix, Unité de soins intensifs, Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Unité de soins intensifs [Clermont Ferrand], CHU Clermont-Ferrand-CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand, Service de réanimation médicale polyvalente [CHU Cochin], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital pasteur [Colmar], Service de réanimation médicale, Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Service de réanimation médicale et infectieuse, Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Hôpital Mignot, Hôpital les oudaries, Agence régionale d'hospitalisation d'Ile de France, ARH Ile de France, Medical Intensive Care Unit, Hôpital Bichat, Réanimation polyvalente, Université Paris Descartes - Paris 5 (UPD5)-Groupe Hospitalier Paris Saint-Joseph, Service d'anesthesiologie, Hôpital Saint Joseph, OUTCOMEREA Study Group, Vesin, Aurélien, Groupe Hospitalier Paris Saint-Joseph (hpsj), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale (INSERM)-Département de biostatistiques, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Université Paris Descartes - Paris 5 (UPD5)-Groupe Hospitalier Paris Saint-Joseph (hpsj), Institut d'oncologie/développement Albert Bonniot de Grenoble ( INSERM U823 ), Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-EFS-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Département de biostatistiques, Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-Hôpital Albert Michallon-Hôpital Albert Michallon, Université Joseph Fourier - Grenoble 1 ( UJF ) -CHU Grenoble-Hôpital Albert Michallon, Centre Hospitalier Régional Universitaire de Nîmes ( CHRU Nîmes ), CHU Clermont-Ferrand-Hôpital Gabriel Montpied, Assistance publique - Hôpitaux de Paris (AP-HP)-CHU Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP)-Université Paris Diderot - Paris 7 ( UPD7 ) -Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Université Paris Diderot - Paris 7 ( UPD7 ), and Université Paris Descartes - Paris 5 ( UPD5 ) -Groupe Hospitalier Paris Saint-Joseph
- Subjects
Male ,Delphi Technique ,MESH : Safety Management ,MESH : Insulin ,MESH: Medical Errors ,MESH : Aged ,MESH : Prospective Studies ,MESH: Medication Errors ,MESH : Medical Audit ,Critical Care and Intensive Care Medicine ,MESH: Medical Audit ,MESH: Delphi Technique ,law.invention ,Cohort Studies ,0302 clinical medicine ,MESH : Cross-Sectional Studies ,MESH: Aged, 80 and over ,law ,Insulin ,Medication Errors ,MESH : Female ,030212 general & internal medicine ,Hospital Mortality ,Prospective Studies ,MESH: Incidence ,MESH: Cohort Studies ,Aged, 80 and over ,MESH: Aged ,Medical Audit ,MESH: Middle Aged ,Medical Errors ,Incidence (epidemiology) ,Incidence ,[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie ,Middle Aged ,MESH : Adult ,Intensive care unit ,MESH : Incidence ,3. Good health ,Intensive Care Units ,Female ,France ,MESH : Intensive Care Units ,Cohort study ,Pulmonary and Respiratory Medicine ,Adult ,medicine.medical_specialty ,Safety Management ,animal structures ,MESH : Medication Errors ,MESH : Male ,MESH : Medical Errors ,MESH : Cohort Studies ,MESH: Insulin ,MESH: Multivariate Analysis ,MESH : Hospital Mortality ,03 medical and health sciences ,MESH: Cross-Sectional Studies ,MESH : Quality Indicators, Health Care ,Intensive care ,medicine ,MESH: Quality Indicators, Health Care ,Humans ,MESH : Middle Aged ,MESH: Hospital Mortality ,Intensive care medicine ,Adverse effect ,MESH : Aged, 80 and over ,MESH : France ,Aged ,Quality Indicators, Health Care ,MESH: Humans ,business.industry ,MESH : Humans ,MESH : Multivariate Analysis ,030208 emergency & critical care medicine ,MESH: Adult ,MESH: Male ,MESH: Prospective Studies ,MESH: France ,Cross-Sectional Studies ,MESH: Safety Management ,MESH : Delphi Technique ,[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie ,Emergency medicine ,Multivariate Analysis ,Observational study ,MESH: Intensive Care Units ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,MESH: Female - Abstract
International audience; RATIONALE: Although intensive care units (ICUs) were created for patients with life-threatening illnesses, the ICU environment generates a high risk of iatrogenic events. Identifying medical errors (MEs) that serve as indicators for iatrogenic risk is crucial for purposes of reporting and prevention. OBJECTIVES: We describe the selection of indicator MEs, the incidence of such MEs, and their relationship with mortality. METHODS: We selected indicator MEs using Delphi techniques. An observational prospective multicenter cohort study of these MEs was conducted from March 27 to April 3, 2006, in 70 ICUs; 16 (23%) centers were audited. Harm from MEs was collected using specific scales. MEASUREMENTS AND MAIN RESULTS: Fourteen types of MEs were selected as indicators; 1,192 MEs were reported for 1,369 patients, and 367 (26.8%) patients experienced at least 1 ME (2.1/1,000 patient-days). The most common MEs were insulin administration errors (185.9/1,000 d of insulin treatment). Of the 1,192 medical errors, 183 (15.4%) in 128 (9.3%) patients were adverse events that were followed by one or more clinical consequences (n = 163) or that required one or more procedures or treatments (n = 58). By multivariable analysis, having two or more adverse events was an independent risk factor for ICU mortality (odds ratio, 3.09; 95% confidence interval, 1.30-7.36; P = 0.039). CONCLUSIONS: The impact of medical errors on mortality indicates an urgent need to develop prevention programs. We have planned a study to assess a program based on our results.
- Published
- 2010
- Full Text
- View/download PDF
24. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine
- Author
-
Yann-Erick Claessens, Elie Azoulay, Mehran Monchi, Alain Cariou, Philippe Rouges, Dany Goldgran-Toledano, Lilia Soufir, Jean-François Dhainaut, and Fabienne Branche
- Subjects
Adult ,Male ,HIV Infections ,Critical Care and Intensive Care Medicine ,Antiviral Agents ,Virus ,chemistry.chemical_compound ,Carnitine ,Medicine ,Humans ,Lactic Acid ,Prospective Studies ,Acidosis ,Retrospective Studies ,Nucleoside analogue ,business.industry ,Middle Aged ,medicine.disease ,Lactic acid ,Survival Rate ,chemistry ,Lactic acidosis ,Immunology ,Reverse Transcriptase Inhibitors ,Acidosis, Lactic ,Female ,Viral disease ,medicine.symptom ,business ,Nucleoside ,medicine.drug - Abstract
Our first objective was to determine a blood lactate threshold predictive of survival in human immunodeficiency virus patients experiencing lactic acidosis related to nucleoside analogs, and second, to test l-carnitine for the treatment of patients exceeding that threshold.a) Retrospective study using data from personal and published observations to determine the lactate threshold between survivors and nonsurvivors in human immunodeficiency virus patients being treated with nucleoside analogs. b) Prospective multicenter open trial to test l-carnitine treatment of human immunodeficiency virus patients receiving nucleoside analogs.Medical intensive care units of four teaching hospitals and one general hospital.Retrospective analysis of data from 39 human immunodeficiency virus patients (five personal cases and 34 patients from the literature) receiving nucleoside-analog treatment from which lactate values were available. An additional six patients with high lactate values were included as a pilot study testing the use of l-carnitine therapy.An initial lactate level of 9 mmol/L, which gave good positive and negative predictive values, was determined as a threshold between survivors and nonsurvivors for the patients receiving nucleoside-analog treatment. Six patients with initial lactate levels10 mmol/L were prospectively treated with l-carnitine; three survived beyond the end of the study.The blood lactate levels in human immunodeficiency virus patients receiving nucleoside-analog therapy can predict mortality in these patients. The preliminary data from this pilot study suggest that l-carnitine may be helpful for patients who have nucleoside-analog-related lactic acidosis with blood lactate levels10 mmol/L. Further studies will be necessary to affirm the therapeutic efficacy of l-carnitine in this setting.
- Published
- 2003
25. Can Nosocomial Infections and Iatrogenic Events Serve as Quality-of-Care Indicators in the ICU?
- Author
-
M. Garrouste Orgeas, Lilia Soufir, and Jean-François Timsit
- Subjects
Adult intensive care unit ,business.industry ,media_common.quotation_subject ,Medicine ,Quality (business) ,Medical emergency ,Institute of medicine ,Quality of care ,business ,medicine.disease ,Respir crit ,media_common - Abstract
The measurement of quality of care is receiving increasing attention from intensivists. Quality of care can be measured in many different domains. In a hospital, quality of care depends both on the quality of the economic and organizational operation of the institution (evaluated by managers, decision-makers, and politicians) and on the quality of clinical activities. This last component is familiar ground to caregivers and patients, since it is centered on the patients and their interactions with the institution. A recent report from the Institute of Medicine identified six quality goals: care should be safe, effective, patient-centered, timely, efficient, and equitable [1].
- Published
- 2003
- Full Text
- View/download PDF
26. Na(+)-K(+)-ATPase alpha(2)-isoform expression in guinea pig hearts during transition from compensation to decompensation
- Author
-
François Carré, Ioulia Belikova, Juan Fernando Ramirez-Gil, Christophe Leclercq, Pascal Trouvé, Danièle Charlemagne, Thierry Dakhli, Isabelle Ray Coquard, and Lilia Soufir
- Subjects
Gene isoform ,medicine.medical_specialty ,Physiology ,Sodium-Potassium-Exchanging ATPase ,Guinea Pigs ,Biology ,Guinea pig ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Decompensation ,RNA, Messenger ,Na+/K+-ATPase ,Heart Failure ,Sarcolemma ,Sodium-calcium exchanger ,Myocardium ,Adaptation, Physiological ,Rats ,Isoenzymes ,Endocrinology ,Biophysics ,Female ,Hypertrophy, Left Ventricular ,Cardiology and Cardiovascular Medicine ,Intracellular - Abstract
Disturbance in ionic gradient across sarcolemma may lead to arrhythmias. Because Na+-K+-ATPase regulates intracellular Na+and K+concentrations, and therefore intracellular Ca2+concentration homeostasis, our aim was to determine whether changes in the Na+-K+-ATPase α-isoforms in guinea pigs during transition from compensated (CLVH) to decompensated left ventricular hypertrophy (DLVH) were concomitant with arrhythmias. After 12- and 20-mo aortic stenosis, CLVH and DLVH were characterized by increased mean arterial pressure (30% and 52.7%, respectively). DLVH differed from CLVH by significantly increased end-diastolic pressure (34%), decreased sarco(endo)plasmic reticulum Ca2+-ATPase (−75%), and increased Na+/Ca2+exchanger (25%) mRNA levels and by the occurrence of ventricular arrhythmias. The α-isoform (mRNA and protein levels) was significantly lower in DLVH (2.2 ± 0.2- and 1.4 ± 0.15-fold, respectively, vs. control) than in CLVH (3.5 ± 0.4- and 2.2 ± 0.13-fold, respectively) and was present in sarcolemma and T tubules. Changes in the levels of α1- and α3-isoform in CLVH and DLVH appear physiologically irrelevant. We suggest that the increased level of α2-isoform in CLVH may participate in compensation, whereas its relative decrease in DLVH may enhance decompensation and arrhythmias.
- Published
- 2000
27. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study
- Author
-
Jean-François Timsit, Bernard Regnier, Jean Carlet, Sylvie Chevret, Lilia Soufir, and Cedric Mahé
- Subjects
Microbiology (medical) ,Male ,medicine.medical_specialty ,Pediatrics ,Catheterization, Central Venous ,Epidemiology ,Critical Illness ,law.invention ,Cohort Studies ,law ,Risk Factors ,Sepsis ,Severity of illness ,medicine ,Humans ,Hospital Mortality ,Prospective Studies ,Risk factor ,APACHE ,Cross Infection ,business.industry ,Organ dysfunction ,Bacterial Infections ,Middle Aged ,Intensive care unit ,Intensive Care Units ,Infectious Diseases ,Mycoses ,SAPS II ,Relative risk ,Attributable risk ,Emergency medicine ,Female ,France ,medicine.symptom ,Morbidity ,business ,Cohort study - Abstract
Objective:To determine the attributable risk of death due to catheter-related septicemia (CRS) in critically ill patients when taking into account severity of illness during the intensive-care unit (ICU) stay but before CRS.Design:Pairwise-matched (1:2) exposed-unexposed study.Setting:10-bed medical-surgical ICU and an 18-bed medical ICU.Patients:Patients admitted to either ICU between January 1, 1990, and December 31, 1995, were eligible. Exposed patients were defined as patients with CRS; unexposed controls were selected according to matching variables.Methods:Matching variables were diagnosis at ICU admission, length of central catheterization before the infection, McCabe Score, Simplified Acute Physiologic Score (SAPS) II at admission, age, and gender. Severity scores (SAPS II, Organ System Failure Score, Organ Dysfunction and Infection Score, and Logistic Organ Dysfunction System) were calculated four times for each patient: the day of ICU admission, the day of CRS onset, and 3 and 7 days before CRS. Matching was successful for 38 exposed patients. Statistical analysis was based on nonparametric tests for epidemiological data and on Cox's models for the exposed-unexposed study, with adjustment on matching variables and prognostic factors of mortality.Results:CRS complicated 1.17 per 100 ICU admissions during the study period. Twenty (53%) of the CRS cases were associated with septic shock. CRS was associated with a 28% increase in SAPS II. Crude ICU mortality rates from exposed and unexposed patients were 50% and 21%, respectively. CRS remained associated with mortality even when adjusted on other prognostic factors at ICU admission (relative risk [RR], 2.01; 95% confidence interval [CI95], 1.08-3.73; P=.03). However, after adjustment on severity scores calculated between ICU admission and 1 week before CRS, the increased mortality was no longer significant (RR, 1.41; CI95, 0.76-2.61; P=.27).Conclusion:CRS is associated with subsequent morbidity and mortality in the ICU, even when adjusted on severity factors at ICU admission. However, after adjustment on severity factors during the ICU stay and before the event, there was only a trend toward CRS-attributable mortality. The evolution of patient severity should be taken into account when evaluating excess mortality induced by nosocomial events in ICU patients.
- Published
- 1999
28. Management of thrombocytopenia in the ICU (pregnancy excluded)
- Author
-
Bertrand Souweine, Lilia Soufir, Laurent Dupic, Thierry Van Der Linden, and Pascal Meyer
- Subjects
medicine.medical_specialty ,Pregnancy ,Thrombotic microangiopathy ,business.industry ,Guideline ,Review ,Critical Care and Intensive Care Medicine ,medicine.disease ,Intensive care unit ,Thrombocytopenia ,law.invention ,Expert recommendations ,Critical care ,law ,Intensive care ,Anesthesiology ,Epidemiology ,Emergency medicine ,medicine ,Etiology ,Adults ,Intensive care medicine ,business - Abstract
Thrombocytopenia is a very frequent disorder in the intensive care unit. Many etiologies should be searched, and therapeutic approaches differ according to these different causes. However, no guideline exists regarding optimum practices for these situations in critically ill patients. We present recommendations for the management of thrombocytopenia in intensive care unit, excluding pregnancy, developed by an expert group of the French-Language Society of Intensive Care (Societe de Reanimation de Langue Francaise (SRLF), the French Language Group of Paediatric Intensive Care and Emergencies (GFRUP) and of the Haemostasis and Thrombosis Study Group (GEHT) of the French Society of Haematology (SFH). The recommendations cover six fields of application: definition, epidemiology, and prognosis; diagnostic approach; therapeutic aspects; thrombocytopenia and sepsis; iatrogenic thrombocytopenia, with a special focus on heparin-induced thrombocytopenia; and thrombotic microangiopathy.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.